
On Sept. 9, 2024, the Departments of Labor, Health and Human Services, and the Treasury (Departments) released a final rule to strengthen the requirements of the Mental Health Parity and Addiction Equity Act (MHPAEA). The final rule is designed to ensure that individuals do not face greater restrictions to obtaining mental health and substance use disorder (MH/SUD) benefits than they would face for medical/surgical benefits.
The final rule adds protections against more restrictive nonquantitative treatment limitations (NQTLs), such as preauthorization requirements and network composition standards. For example, the final rule requires group health plans and health insurance issuers to collect and evaluate data related to the NQTLs they place on MH/SUD care and make changes if the data shows they are providing insufficient access.
The final rule also establishes minimum standards for developing comparative analyses to assess whether NQTLs comply with MHPAEA’s requirements. In most cases, employers rely on issuers and third-party vendors to prepare comparative analyses for their health plans. However, the final rule requires the comparative analyses for health plans covered by ERISA to include a fiduciary’s certification that they have engaged in a prudent process and monitored their service providers.
The final rule generally applies for plan years beginning on or after Jan. 1, 2025; however, certain key requirements, such as NQTL data requirements, apply for plan years beginning on or after Jan. 1, 2026.
Contact us to see how you could minimize risk:
Recent News
How AI Is Reshaping the Labor Market
Hiring patterns are changing, entry-level pipelines are thinning and the types of roles employers are actively seeking are moving.
Compliance Update: Allegheny County Advances Revised Paid Parental Leave Proposal
Allegheny County’s revised proposal would require up to 12 weeks of paid parental leave
Seubert Webinar Recap: Pharmacy Benefits Beyond the Rebate
Missed our pharmacy benefits webinar? Get the key takeaways on rebates, biosimilars, GLP-1 coverage, specialty drugs and PBM transparency, plus the recording.
Employee Spotlight: Gianna Mancino
Please join us in welcoming Gianna Mancino to the Seubert Team!
Zero-day Vulnerabilities Explained
A zero-day vulnerability may go undetected or otherwise unresolved for an extended period, quietly existing within an organization’s broader IT infrastructure without affecting typical operations.
Employee Spotlight: Dylan Ward
Please help us welcome Dylan Ward to the Seubert Team as a Surety Operations Specialist in our Surety Bond Division!

